Brown Advisory Securities, LLC Eli Lilly & CO Transaction History

Brown Advisory Securities, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $262,374 - $322,888	-1,184 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $213,771 - $276,511	1,184 New	1,184 $272,000
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $455,988 - $590,298	-2,775 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $69,847 - $84,060	-512 Reduced 15.58%	2,775 $455,000
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $15,952 - $19,744	134 Added 4.25%	3,287 $466,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $49,076 - $60,785	-459 Reduced 12.71%	3,153 $415,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $250,956 - $272,976	-2,350 Reduced 39.42%	3,612 $405,000
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $309,214 - $360,932	-2,791 Reduced 31.89%	5,962 $659,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $102,739 - $120,931	-923 Reduced 9.54%	8,753 $1.13 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $74,553 - $83,522	-704 Reduced 6.78%	9,676 $1.11 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $28,333 - $35,412	-330 Reduced 3.08%	10,380 $1.12 Million
Q2 2018 Aug 03, 2018	BUY	$75.7 - $86.88 $15,897 - $18,244	210 Added 2.0%	10,710 $915,000
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $4,823 - $5,694	65 Added 0.62%	10,500 $811,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $60,307 - $64,687	736 Added 7.59%	10,435 $881,000
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $24,970 - $27,714	324 Added 3.46%	9,699 $828,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,375	9,375 $769,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Securities, LLC with notifications on news.